Dr. Cohen on the Timing of ctDNA Testing in Resected Stage I-III CRC
January 31st 2023Stacey A. Cohen, MD, discusses the investigation of the optimal timing to test for circulating tumor DNA to detect minimal residual disease following surgery in patients with stage I to III colorectal cancer.
Read More